O-GlcNAcylation in tumorigenesis and its implications for cancer therapy
Journal of Biological Chemistry · 2024-09 · 300 (9) · 107709
DOI: 10.1016/j.jbc.2024.107709 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Biological Chemistry, 2024-09. Verfasst von Dize Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China; Key Laboratory for Tumor Precision Medicine of Shaan…. Hauptthemen laut MEDLINE: Neoplasms, N-Acetylglucosaminyltransferases, Protein Processing, Post-Translational, Acetylglucosamine. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 128 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Key Research and Development Program of China, National Institutes of Health.
Abstract (Originalsprache)
O-linked N-acetylglucosaminylation (O-GlcNAcylation) is a dynamic and reversible posttranslational modification that targets serine and threonine residues in a variety of proteins. Uridine diphospho-N-acetylglucosamine, which is synthesized from glucose via the hexosamine biosynthesis pathway, is the major donor of this modification. O-GlcNAc transferase is the sole enzyme that transfers GlcNAc onto protein substrates, while O-GlcNAcase is responsible for removing this modification. O-GlcNAcylation plays an important role in tumorigenesis and progression through the modification of specific protein substrates. In this review, we discuss the tumor-related biological functions of O-GlcNAcylation and summarize the recent progress in the development of pharmaceutical options to manipulate the O-GlcNAcylation of specific proteins as potential anticancer therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China; Key Laboratory for Tumor Precision Medicine of Shaanxi Province, The First Affiliated Hospital of Xi'an Jiaotong Universit…
- Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, United States.
- Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, United States. Electronic address: wwei2@bidmc.harvard.edu.
Förderung
- NCI NIH HHS
- National Key Research and Development Program of China
- National Institutes of Health
- National Cancer Institute
Zitieren
APA
Zhang, D., Qi, Y., Inuzuka, H., Liu, J., & Wei, W. (2024). O-GlcNAcylation in tumorigenesis and its implications for cancer therapy. Journal of Biological Chemistry, 300(9), 107709. https://doi.org/10.1016/j.jbc.2024.107709
Vancouver
Zhang D, Qi Y, Inuzuka H, Liu J, Wei W. O-GlcNAcylation in tumorigenesis and its implications for cancer therapy. Journal of Biological Chemistry. 2024;300(9):107709. doi:10.1016/j.jbc.2024.107709
BibTeX
@article{Zhang2024,
author = {Zhang, Dize and Qi, Yihang and Inuzuka, Hiroyuki and Liu, Jing and Wei, Wenyi},
title = {O-GlcNAcylation in tumorigenesis and its implications for cancer therapy},
journal = {Journal of Biological Chemistry},
year = {2024},
volume = {300},
number = {9},
pages = {107709},
doi = {10.1016/j.jbc.2024.107709}
}
EUVIMED